Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Severe demyelination but no astrocytopathy in clinically definite neuromyelitis optica with anti-myelin-oligodendrocyte glycoprotein antibody.
Aquaporin-4: A novel diagnostic biomarker for seronegative neuromyelitis optica.
Conclusion: National incidence and risk factor assessments may become a basis for the evaluation of prevention trials - prospects from the Third Nordic MS Symposium.
Roles of T helper 17 cells and interleukin-17 in neuroautoimmune diseases with emphasis on multiple sclerosis and Guillain-Barré syndrome as well as their animal models.
Neuroprotective effect of melatonin in experimental optic neuritis in rats.
Characteristics, diagnosis and outcome of patients referred to a specialized neurology emergency clinic: prospective observational study.
Expression Profile of Long Non-Coding RNAs in Serum of Patients with Multiple Sclerosis.
Patterns in workplace accommodations for people with multiple sclerosis to overcome cognitive and other disease-related limitations.
Genetic Creutzfeldt-Jakob disease mimicking chronic inflammatory demyelinating polyneuropathy.
Dissecting the role of E2 protein domains on alphavirus pathogenicity.
Brain magnetic resonance imaging helps to differentiate atypical multiple sclerosis with cavitary lesions and vanishing white matter disease.
Integrated sphingosine-1 phosphate signaling in the central nervous system: From physiological equilibrium to pathological damage.
Role of toll-like receptors in multiple sclerosis.
Multiple sclerosis and pregnancy: a comparison study.
Bilateral claw hand: An uncommon presentation of regional Guillain-Barré syndrome.
Circulating dendritic cells of multiple sclerosis patients are proinflammatory and their frequency is correlated with MS-associated genetic risk factors.
Low contrast visual acuity testing is associated with cognitive performance in multiple sclerosis: a cross-sectional pilot study.
Interleukin-7 Receptor Single Nucleotide Polymorphism rs6897932 (C/T) and the Susceptibility to Systemic Lupus Erythematosus.
New diagnostic criteria for multiple sclerosis in patients with clinically isolated syndromes: Some questions could be raised during clinical practice.
Clinical, MRI, and CSF Markers of Disability Progression in Multiple Sclerosis.
Forceps minor damage and co-occurrence of depression and fatigue in multiple sclerosis.
Astrocyte-derived BDNF supports myelin protein synthesis after cuprizone-induced demyelination.
Th17 Pathway As a Target for Multipotent Stromal Cell Therapy in Dogs: Implications for Translational Research.
Effects of High Glucose on Cell Viability and Differentiation in Primary Cultured Schwann Cells: Potential Role of ERK Signaling Pathway.
Quantifying Demyelination in NK venom treated nerve using its electric circuit model.
Pages
« first
‹ previous
…
651
652
653
654
655
656
657
658
659
…
next ›
last »